Comparing two ovarian stimulation medications for egg donors
Part of Women’s health & pregnancy clinical trials.
This trial compares two different medications (Corifollitropin alpha and daily rFSH) to stimulate egg production in healthy egg donors. It aims to see if a single injection of Corifollitropin alpha works as well as the usual daily shots, making the process simpler and more comfortable.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 35 years old.
- You have regular menstrual cycles (every 25 to 35 days).
- Your body mass index (BMI) is between 18 and 28.
- You have no serious health conditions like diabetes, blood clots, or cancer.
- You are not using long-term hormonal birth control (like an IUD or implant).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two methods of temporarily 'turning off' the pituitary gland to prepare for egg donation. It may be a good fit if you are healthy, have good ovarian reserve (shown by follicles on ultrasound), and meet egg donation program rules.
This trial tests a 'one-shot' ovarian stimulation protocol (a single injection to help your ovaries produce eggs). It is for women with good ovarian reserve who fit certain age and health requirements, and aims to simplify the treatment process.
This trial tests whether a lower or higher dose of follicle-stimulating hormone (FSH) works better for women with normal egg supply. If you are starting your first or second IVF cycle, you may be able to join.
This trial studies whether a “mechanical stimulation” procedure can help small egg-making structures in the ovary start to work again in people with primary ovarian insufficiency. If the procedure shows signs of response, you may then move on to further fertility treatment, including IVF.
This trial tests a fertility injection called Corifollitropin alfa to help women aged 36–40 produce eggs for in-vitro fertilization (IVF). Researchers want to confirm it is safe and effective in this age group using a specific ovarian stimulation protocol.
This study tests if a combination of two hormone drugs (follitropin alfa/lutropin alfa) works as well as another drug (hMG) for Japanese women with low LH and FSH levels who are doing in vitro fertilization (IVF). The goal is to help them produce eggs for pregnancy.
Hear when a new Infertility, Female trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.